Artiva Biotherapeutics, Inc. ARTV Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s total equity?
- Artiva Biotherapeutics, Inc. (ARTV) reported total equity of $87.85M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s total equity changed year-over-year?
- Artiva Biotherapeutics, Inc.'s total equity decreased by 48.0% year-over-year, from $168.78M to $87.85M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s total equity?
- Over 3 years (2022 to 2025), Artiva Biotherapeutics, Inc.'s total equity has grown at a -7.9% compound annual growth rate (CAGR), from -$140.7M to $109.97M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.